Cargando…
Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies
Mitochondrial fatty acid oxidation (FAO) and respiratory chain (RC) defects form a large group of inherited monogenic disorders sharing many common clinical and pathophysiological features, including disruption of mitochondrial bioenergetics, but also, for example, oxidative stress and accumulation...
Autores principales: | Djouadi, Fatima, Bastin, Jean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523966/ https://www.ncbi.nlm.nih.gov/pubmed/30925787 http://dx.doi.org/10.3390/cells8040289 |
Ejemplares similares
-
Resveratrol and Myopathy
por: Bastin, Jean, et al.
Publicado: (2016) -
Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration
por: Bastin, Jean, et al.
Publicado: (2023) -
Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts
por: Aires, Virginie, et al.
Publicado: (2014) -
Mitochondrial Fatty Acid β-Oxidation and Resveratrol Effect in Fibroblasts from Patients with Autism Spectrum Disorder
por: Barone, Rita, et al.
Publicado: (2021) -
Pharmacological advances in mitochondrial therapy
por: Singh, Aarti, et al.
Publicado: (2021)